调节受体活动的蛋白3增强GLP-1介导的胰岛素分泌
Abigail Pearce1, Poonam Kumari2, Claudia M Sisk1
1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK.
The Journal of biological chemistry
|August 20, 2025
概括
受体活性修饰蛋白3 (RAMP3) 调节类似葡萄糖-1受体 (GLP-1R) 信号,增强胰岛素分泌. 这种相互作用可能会减少与目前用于糖尿病和肥胖的GLP- 1R疗法的副作用.
科学领域:
- 药理学
- 内分泌学
- 分子生物学
背景情况:
- 葡萄糖类-1受体 (GLP-1R) 激动剂对糖尿病和肥胖有效,但会引起副作用.
- 受体活性修饰蛋白 (RAMPs) 可以改变激素的结合和信号传递,从而可能减轻不良反应.
- RAMPs提供了一种开发更有选择性的GLP-1R治疗方法的策略.
研究的目的:
- 研究GLP-1R和RAMP3之间的相互作用.
- 确定RAMP3如何影响GLP-1R信号通路.
- 评估GLP-1R-RAMP3相互作用对代谢疾病的治疗潜力.
主要方法:
- 证实GLP- 1R和RAMP3相互作用的同时免疫沉.
- 细胞内 (Ca2+) 和循环腺单 (cAMP) 信号的测量.
- 在GLP-1R激活时分析G蛋白合 (Gαs,Gαq,Gαi).
- 使用RAMP3敲除小鼠进行葡萄糖和胰岛素耐受性测试的体内研究.
主要成果:
- 在细胞表面,GLP- 1R与RAMP3形成一个功能性异构体.
- RAMP3表达将GLP-1R信号从cAMP转移到Ca2+调动.
- 通过改变G蛋白合,RAMP3增强了GLP-1诱导的胰岛素分泌.
- 在葡萄糖和胰岛素耐受性测试中,Ramp3淘汰小鼠对GLP-1的敏感性降低.
结论:
- RAMP3 作为GLP-1R功能的一个关键调节器.
- GLP- 1R- RAMP3相互作用为改善代谢控制提供了一个新的治疗点.
- 了解这种相互作用可以指导下一代基于GLP-1R的药物的设计,以提高安全性.
相关概念视频
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Dipeptidyl Peptidase 4 Inhibitors
256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Oral Hypoglycemic Agents: Glinides
257
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
257
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K


